CoViD-19 e Cronicità
Patologie neurologiche
Patologie neurologiche
-
Iodice et al.
Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations.
Neurol Sci. 2021 Jan 7;1-11.
Review sugli effetti diretti e indiretti del CoViD-19 sui pazienti con disturbi cognitivi
-
Bova et al.
Impact of COVID-19 lockdown in children with neurological disorders in Italy.
Disabil Health J. 2020 Dec 16.
Studio sull’impatto del lockdown sui bimbi con disturbi neurologici in Italia
-
Postiglione et al.
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management.
Brain Behav. 2020 Nov 28;e01955.
Studio sull’impatto indiretto del CoViD-19 sulla gestione della narcolessia
-
Shaygannejad et al.
Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus.
Neurol Sci. 2020 Nov 20.
Studio sugli effetti indiretti del CoViD-19 sui pazienti con sclerosi multipla o altri disturbi neurologici
-
Altamura et al.
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
Neurol Sci. 2020 Dec;41(12):3385-3389.
Studio sull’impatto indiretto del CoViD-19 sulla gestione della terapia dell’emicrania
-
Šagát et al.
Impact of COVID-19Quarantine on Low Back Pain Intensity, Prevalence, and Associated Risk Factors among Adult Citizens Residing in Riyadh (Saudi Arabia): A Cross-Sectional Study.
Int. J. Environ. Res. Public Health 2020, 17, 7302. 6 October 2020.
Studio sull’impatto del lockdown sul dolore lombare
-
Vogel et al.
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
Mult Scler Relat Disord. 2020 Sep 19.
Impatto del CoViD-19 sui pazienti con sclerosi multipla
-
Prasad et al.
Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson’s Disease.
Neurol India Jul-Aug 2020;68(4):792-795. .
Studio sull’impatto del lockdown per il CoViD-19 sui pazienti con Parkinson